Page 4 - Pnt O News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pnt o. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pnt O Today - Breaking & Trending Today

POINT Biopharma Global (NASDAQ:PNT) Releases Earnings Results

POINT Biopharma Global (NASDAQ:PNT – Get Free Report) issued its quarterly earnings data on Monday. The company reported ($0.23) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.30) by $0.07, MarketWatch Earnings reports. The business had revenue of $2.79 million during the quarter, compared to the consensus estimate of $8.00 million. POINT […] ....

Leerink Partnrs , William Blair , Principal Financial Group Inc , Capital Management , Biopharma Global Inc , Tower Research Capital , Get Free Report , Marketwatch Earnings , Global Stock , Research Capital , Financial Group , Global Inc , Global Daily , Point Biopharma Global , Nasdaq Pnt ,

FY2023 EPS Estimates for POINT Biopharma Global Inc. Increased by Analyst (NASDAQ:PNT)

POINT Biopharma Global Inc. (NASDAQ:PNT – Free Report) – Investment analysts at Leerink Partnrs raised their FY2023 earnings per share (EPS) estimates for shares of POINT Biopharma Global in a report issued on Monday, November 13th. Leerink Partnrs analyst F. Khurshid now expects that the company will post earnings of ($0.95) per share for the […] ....

Leerink Partnrs , Dekabank Deutsche Girozentrale , Piper Sandler , William Blair , Beutel Goodman Co Ltd , Tower Research Capital , Jefferies Financial Group , Biopharma Global Inc , Principal Financial Group Inc , Point Biopharma Global Inc , Free Report , Get Free Report , Bank Deutsche Girozentrale , Research Capital , Principal Financial Group , Global Inc , Global Daily , Point Biopharma Global , Nasdaq Pnt , Earnings Estimates ,

POINT Biopharma Global (NASDAQ:PNT) Hits New 12-Month High at $13.36

POINT Biopharma Global Inc. (NASDAQ:PNT – Get Free Report)’s share price reached a new 52-week high on Monday . The stock traded as high as $13.36 and last traded at $13.36, with a volume of 1201 shares trading hands. The stock had previously closed at $13.12. Analyst Upgrades and Downgrades Several equities analysts have recently […] ....

Leerink Partnrs , Raymond James , Dekabank Deutsche Girozentrale , Principal Financial Group Inc , Beutel Goodman Co Ltd , Jefferies Financial Group , Biopharma Global Company Profile , Point Biopharma Global Inc , Tower Research Capital , Biopharma Global Inc , Get Free Report , Financial Group , Bank Deutsche Girozentrale , Research Capital , Principal Financial Group , Global Company , Global Inc , Global Daily , Point Biopharma Global , Nasdaq Pnt ,

POINT Biopharma Global (NASDAQ:PNT) Given "Neutral" Rating at Piper Sandler

POINT Biopharma Global (NASDAQ:PNT – Get Free Report)‘s stock had its “neutral” rating reiterated by equities researchers at Piper Sandler in a research report issued to clients and investors on Tuesday, Benzinga reports. They presently have a $12.50 price objective on the stock. Piper Sandler’s target price suggests a potential downside of 2.19% from the […] ....

Leerink Partnrs , Raymond James , Piper Sandler , Vanguard Group Inc , Biopharma Global Inc , Swiss National Bank , Jefferies Financial Group , Biopharma Global Company Profile , Citigroup Inc , Cibc World Market Inc , Get Free Report , Financial Group , Global Price , National Bank , Montreal Can , World Market , Vanguard Group , Global Company , Global Inc , Global Daily , Point Biopharma Global , Nasdaq Pnt , Reiterated Rating ,